lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
274 rows where filing_period = "second_quarter", filing_year = 2017 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1982016 | BOCKORNY GROUP, INC. c3ffade5-2e08-4932-b30d-072d66d652f0 | 2T | BOCKORNY GROUP, INC. | 289773 | BLACK BERET LIFE SCIENCES LLC (FORMERLY REPORTING AS BOSARGE LIFE SCIENCES) | 2017 | second_quarter | MED | Issues related to the 21st Century Cures Initiative Issues related to FDA reform | HOUSE OF REPRESENTATIVES,SENATE | 25000 | 0 | 1 | 2017-06-08T15:39:48.427000-04:00 | |
| 1982470 | MR. BRIAN KELLY d2cc2ae5-ba0f-4bce-9180-c6aa128f2d9a | Q2 | MR. BRIAN KELLY | 40024191 | INTELLIA THERAPEUTICS | 2017 | second_quarter | MED | Gene Editing | Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office | 15000 | 0 | 0 | 2017-06-30T10:54:11.893000-04:00 | |
| 1982475 | MR. BRIAN KELLY 3055e158-1468-402f-adf1-3fce81115852 | Q2 | MR. BRIAN KELLY | 40024191 | LUNDBECK PHARMACEUTICALS | 2017 | second_quarter | MED | Brain Disorders CNS Alzheimer's | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2017-06-30T10:55:16.673000-04:00 | |
| 1982609 | MARSHALL BRACHMAN 6bf295e8-35d6-407f-b7cb-22ef739c8e12 | Q2 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2017 | second_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2017-07-01T17:04:48.950000-04:00 | |
| 1982921 | FRANCIS EDWARD & CRONIN, INC. 1829108b-2fb7-4169-be72-e409790ec844 | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2017 | second_quarter | MED | Legislation related to Alzheimer's disease research. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2017-07-04T21:04:49.333000-04:00 | |
| 1983389 | AMERICAN COLLEGE OF CLINICAL PHARMACY 55f83551-dc10-499b-87c1-0eb70db2ca35 | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2017 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 128375 | 0 | 0 | 2017-07-06T12:18:21.283000-04:00 | |
| 1983473 | NATIONAL BREAST CANCER COALITION FUND b1edc0f7-4e6b-43ef-be76-e1ed8394cf7f | Q2 | NATIONAL BREAST CANCER COALITION FUND | 52652 | NATIONAL BREAST CANCER COALITION FUND | 2017 | second_quarter | MED | HR 1628, the American Health Care Act. Reforming parts of the ACA. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 62251 | 0 | 0 | 2017-07-06T14:26:43.343000-04:00 | |
| 1983538 | UC HEALTH ca5c2b40-568f-4ba1-bf86-376e0791bcda | Q2 | UC HEALTH | 401103195 | UC HEALTH | 2017 | second_quarter | MED | NIH Funding | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2017-07-06T15:25:53.500000-04:00 | ||
| 1983821 | MICHAEL N. MCCARTY LAW OFFICE PLLC 201eea9a-037a-48ea-b827-92731887ee6b | Q2 | MICHAEL N. MCCARTY LAW OFFICE PLLC | 401104300 | AMERICAN MEDICAL TECHNOLOGISTS | 2017 | second_quarter | MED | Regulation of Laboratory Developed Tests; Funding for harmonization of diagnostic test results; House and Senate legislation to repeal and replace or amend the Affordable Care Act, particularly as such legislation may affect access to clinical laboratory services. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-07-07T10:52:10.747000-04:00 | |
| 1983928 | JENNIE AYLWARD a39da428-6f74-4d84-adbe-d567fc713f67 | 2T | JENNIE AYLWARD | 401104208 | PINK RIBBON RED RIBBON | 2017 | second_quarter | MED | Requested support for the U.S. Governments contributions to fight women's cancers in low- and middle-income countries with robust funding for the National Institutes of Health (especially the National Cancer Institute) in FY2018 Labor/HHS/Education appropriations. | HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID) | 10000 | 0 | 1 | 2017-07-07T13:29:51.900000-04:00 | |
| 1983976 | CURATORS OF THE UNIVERSITY OF MISSOURI c29437b0-d688-4d5a-95be-99ee11e5fc86 | Q2 | CURATORS OF THE UNIVERSITY OF MISSOURI | 43616 | CURATORS OF THE UNIVERSITY OF MISSOURI | 2017 | second_quarter | MED | Issues relating to F&A rates for universities. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-07-07T14:18:28.747000-04:00 | |
| 1984236 | NATURAL RESOURCE RESULTS LLC 1403b162-bd2f-4602-94b4-1a6955edb87a | Q2 | NATURAL RESOURCE RESULTS LLC | 321555 | SHINE MEDICAL TECHNOLOGIES | 2017 | second_quarter | MED | Support lifting cap on NNSA program for medical isotope production under AMIPA; support funding SHINE facility under same program at NNSA in FY17 approps and FY18 budget and approps. | Council on Environmental Quality (CEQ),Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 20000 | 0 | 0 | 2017-07-09T19:36:57.933000-04:00 | |
| 1984511 | WAKE FOREST UNIVERSITY HEALTH SCIENCES 20d5b42c-4a2b-4945-8ea6-7fa66c781c92 | Q2 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2017 | second_quarter | MED | VA Research funding | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2017-07-10T14:18:14.870000-04:00 | |
| 1984591 | ALZHEIMER'S FOUNDATION OF AMERICA 0e0d50c4-0cbb-4fc9-b94b-f579f8ca364b | Q2 | ALZHEIMER'S FOUNDATION OF AMERICA | 323158 | ALZHEIMER'S FOUNDATION OF AMERICA | 2017 | second_quarter | MED | S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, Home Health Care Planning Act | Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 30000 | 0 | 0 | 2017-07-10T14:53:16.110000-04:00 | |
| 1985031 | MARSHFIELD CLINIC HEALTH SYSTEM 5e231365-9255-4d8c-aafb-be5807644fd2 | Q2 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2017 | second_quarter | MED | MED (Medical Disease Research/ Clinical Labs) Protecting Access to Medicare Act of 2014 (PAMA) PAMA includes reforms to the Clinical Lab Fee Schedule (CLFS). This rule for PAMA requires reporting of Clinical lab prices and volumes. MCHS requested a delay in the reporting, and changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 90000 | 0 | 0 | 2017-07-11T13:31:19.420000-04:00 | |
| 1985148 | THE CJR GROUP, INC. 68954119-41a2-4b7b-8708-2fdf11ba6fce | Q2 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2017 | second_quarter | MED | Issues impacting hospitals | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-11T14:52:54.617000-04:00 | |
| 1985383 | TCH GROUP, LLC 5d20535e-71af-4a87-a081-c26e06aa9565 | Q2 | TCH GROUP, LLC | 51478 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2017 | second_quarter | MED | FY 18 House and Senate State Foreign Operations Subcommittee Appropriations bill. Specifically, continued Federal funding under USAID for AIDS vaccine research and development | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-11T18:31:50.540000-04:00 | |
| 1985518 | WILLIAMS AND JENSEN, PLLC bdffe766-a3dd-4d68-81da-d6464b35cc72 | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | MT PHARMA AMERICA, INC. | 2017 | second_quarter | MED | Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-12T09:54:32.433000-04:00 | |
| 1985737 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 79a793b2-d4ff-4634-a1f5-7cefadd3a99e | Q2 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 401103605 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 2017 | second_quarter | MED | Lobbied for timely passage of FDA Reauthorization Act (H.R. 2430, S. 934), and provided general education about the pharma/biopharma contract services sector. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-12T12:28:16.063000-04:00 | |
| 1985765 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY c5fb69ac-cf8d-4b42-b495-ed32d87b1c19 | Q2 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 3435 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 2017 | second_quarter | MED | Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases | Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office | 49000 | 0 | 0 | 2017-07-12T12:57:51.493000-04:00 | |
| 1985833 | LEAVITT PARTNERS, LLC 19c1502f-59c0-4a87-a26e-2f59b13fdecc | Q2 | LEAVITT PARTNERS, LLC | 401103367 | 510(K) COALITION | 2017 | second_quarter | MED | Medical Device regulation | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-07-12T13:20:04.923000-04:00 | |
| 1985880 | THE O TEAM LLC a942ea29-21e5-4da9-a6dd-ebcdcddb9b48 | Q2 | THE O TEAM LLC | 400783359 | THE SUZANNE WRIGHT FOUNDATION | 2017 | second_quarter | MED | Pancreatic cancer awareness. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2017-07-12T13:41:56.247000-04:00 | |
| 1986273 | MCDERMOTT+ LLC d304b6ab-6856-46d3-8906-589d2394bf75 | Q2 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2017 | second_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2017-07-13T10:17:51.520000-04:00 | |
| 1986327 | RAY C CULVER III 28b26584-3b43-4290-8349-6973ac80f152 | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2017 | second_quarter | MED | Funding for the USDA Agricultural Research Service human nutrition research centers in both the FY17 Agricultural Appropriations bill (currently PL 114-254) and FY18 Agricultural Appropriations bills. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-07-13T10:39:36.703000-04:00 | |
| 1986440 | THE PETRIZZO GROUP, INC. 854de04f-cd3e-444c-995a-8075d047fbc0 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | FRED HUTCHINSON CANCER RESEARCH CENTER | 2017 | second_quarter | MED | Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-13T11:25:55.317000-04:00 | |
| 1986452 | THE PETRIZZO GROUP, INC. ec093fbd-dc93-4cac-b64d-3b2e3dc95924 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2017 | second_quarter | MED | Advocated for funding of the BRAIN Initiative and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-13T11:27:01.987000-04:00 | |
| 1986475 | THE PETRIZZO GROUP, INC. 36f76b15-c0e8-4c5b-a97f-36ccd969955b | Q2 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2017 | second_quarter | MED | Advocated for Medicare packaged payment reform in Part B. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-13T11:32:23.360000-04:00 | |
| 1986655 | PARRY, ROMANI, DECONCINI & SYMMS 04330c24-d570-416c-8ee5-5b960116827a | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AIDS HEALTHCARE FOUNDATION | 2017 | second_quarter | MED | Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2018 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. | HOUSE OF REPRESENTATIVES,SENATE | 36000 | 0 | 0 | 2017-07-13T13:48:12.973000-04:00 | |
| 1986714 | GRIZZLE COMPANY 88e988c0-d8cd-4b8f-9f2f-25e533de0610 | Q2 | GRIZZLE COMPANY | 16987 | UNIVERSITY OF LOUISVILLE | 2017 | second_quarter | MED | Request letters of support for grant application to the NIMHD. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-13T14:33:00.727000-04:00 | |
| 1986811 | NELSON MULLINS RILEY & SCARBOROUGH 58cda2a3-43ea-4416-80c9-2a1c62c1aaac | Q2 | NELSON MULLINS RILEY & SCARBOROUGH | 285871 | NATERA, INC. | 2017 | second_quarter | MED | Biomedical research, maternal health, and genetic testing | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2017-07-13T15:17:10.513000-04:00 | ||
| 1987189 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER f3e15d53-fdc6-431b-a375-c2a9fc486326 | Q2 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2017 | second_quarter | MED | NIH funding HHS budget bill, PREA re-authorization, cancer moonshot | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 65597 | 0 | 0 | 2017-07-14T09:50:53.123000-04:00 | |
| 1987465 | O'NEILL AND ASSOCIATES 9d0f8e86-66f7-467e-9b08-d938f6d8f532 | Q2 | O'NEILL AND ASSOCIATES | 73134 | POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) | 2017 | second_quarter | MED | Medicare advantage and health care reform | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-14T12:28:56.707000-04:00 | |
| 1987763 | HACKENSACK MERIDIAN HEALTH 9e4cb324-80e0-443d-b5ad-aa4d67acbf26 | Q2 | HACKENSACK MERIDIAN HEALTH | 401104109 | HACKENSACK MERIDIAN HEALTH | 2017 | second_quarter | MED | National Institutes of Health funding Behavioral health Substance abuse, opioids, and patient data | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 40000 | 0 | 0 | 2017-07-14T14:54:14.183000-04:00 | |
| 1987774 | AMERICAN OSTEOPATHIC ASSOCIATION de94c557-2fec-4513-a8eb-f05e69eb5657 | Q2 | AMERICAN OSTEOPATHIC ASSOCIATION | 3014 | AMERICAN OSTEOPATHIC ASSOCIATION | 2017 | second_quarter | MED | NIH; FDA | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office | 291476 | 0 | 0 | 2017-07-14T14:56:16.060000-04:00 | |
| 1987857 | THE FRIEDLANDER GROUP 509fd64e-9096-4285-bb11-d81949fbf73a | Q2 | THE FRIEDLANDER GROUP | 400535604 | OHEL CHILDRENS HOME AND FAMILY SERVICES | 2017 | second_quarter | MED | Block Grants | HOUSE OF REPRESENTATIVES,SENATE | 7500 | 0 | 0 | 2017-07-14T15:29:37.580000-04:00 | |
| 1987936 | HOLLAND & KNIGHT LLP 26d88045-a41a-42d0-b6b2-801894062fdf | Q2 | HOLLAND & KNIGHT LLP | 18466 | THE BIOSIMILARS FORUM | 2017 | second_quarter | MED | Medicare reimbursement issues, FDA regulation of biosimilars; S. 934, H.R. 2430, the FDA Reauthorization Act of 2017. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2017-07-14T15:53:47.137000-04:00 | |
| 1987957 | P STREET PROJECT, INC. 32c805e4-da7f-4fe7-9934-2cbbf01adb75 | Q2 | P STREET PROJECT, INC. | 400637928 | P STREET PROJECT, INC. | 2017 | second_quarter | MED | Public health insurance option and Medicare for All; advocating against repeal of ACA | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-14T16:15:02.727000-04:00 | |
| 1988320 | BROYDRICK & ASSOCIATES d6f9e7cf-6991-412e-ba3e-1bfa014dd19c | Q2 | BROYDRICK & ASSOCIATES | 7268 | EXACT SCIENCES | 2017 | second_quarter | MED | Legislation on cancer screening test process. | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE | 50000 | 0 | 0 | 2017-07-16T19:55:46.990000-04:00 | |
| 1988330 | BROYDRICK & ASSOCIATES b974aa07-a0db-42da-a51f-09f00a44a124 | Q2 | BROYDRICK & ASSOCIATES | 7268 | MORTARA INSTRUMENTS, INC. | 2017 | second_quarter | MED | OFAC licensing. Vender-neutral procurement language. 21st Century cures and E.H.R. interoperability. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2017-07-16T20:02:58.570000-04:00 | ||
| 1988332 | BROYDRICK & ASSOCIATES 22804e0e-70f5-4659-a126-76cf5cca1d94 | Q2 | BROYDRICK & ASSOCIATES | 7268 | NORTHSTAR RADIOISOTOPES, LLC | 2017 | second_quarter | MED | DOE policies and cooperative agreements expansion legislation. Nuclear medicine and CMS Reimbursement. NNSA reorganization, S512 Uranium production (2017). DOE appropriations. | Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2017-07-16T20:04:02.320000-04:00 | ||
| 1988413 | SRI INTERNATIONAL 451b2a1f-6571-425e-a61c-e143867043aa | Q2 | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2017 | second_quarter | MED | FY18 Labor-HHS-Education Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 8000 | 0 | 0 | 2017-07-17T09:11:48.287000-04:00 | |
| 1988648 | PODESTA GROUP, INC. 983597ff-6fcf-4ec9-8488-7e4a37fdebd9 | 2T | PODESTA GROUP, INC. | 31680 | UNIVERSITY OF MIAMI | 2017 | second_quarter | MED | Federal funding for spinal cord injury research. Health research funding. Department of Defense Appropriations. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 1 | 2017-07-17T10:34:37.047000-04:00 | |
| 1988667 | PARALYZED VETERANS OF AMERICA c168a830-ae6d-4ba6-a3c3-92e2ace1555b | Q2 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2017 | second_quarter | MED | Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 82957 | 0 | 0 | 2017-07-17T10:35:47.187000-04:00 | |
| 1989143 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 786bd2c3-cd22-4457-8f09-a26a0dc32c99 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ENDOCRINE SOCIETY | 2017 | second_quarter | MED | Research in Endocrinology | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2017-07-17T13:03:18.757000-04:00 | |
| 1989155 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 99461f34-0edf-49ff-bb35-8bb4cbbd0703 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2017 | second_quarter | MED | Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017 | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2017-07-17T13:07:24.303000-04:00 | |
| 1989163 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f330ee14-120f-4f0c-80dd-907a2abf7929 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2017 | second_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2017-07-17T13:10:29.507000-04:00 | |
| 1989172 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 608b3b91-7921-416a-bfad-dc09258a4834 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2017 | second_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2017-07-17T13:11:30.647000-04:00 | |
| 1989496 | FAEGRE DRINKER BIDDLE & REATH LLP 7a11213e-4825-4d20-bb33-172453dd005e | 2T | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | ALLIANCE FOR BIOSECURITY | 2017 | second_quarter | MED | S. 2055 Medical Countermeasure Innovations Act of 2015 provision regarding priority review vouchers contracting; H.R. 34 21st Century Cures Act; H.R. 3299, Strengthening Public Health Emergency Response Act of 2016, provisions regarding priority review vouchers contracting. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 20000 | 0 | 1 | 2017-07-17T14:39:17.580000-04:00 | |
| 1989725 | MAGNET STRATEGY GROUP f355b10c-bac1-4a48-a6a6-6a103e0fbc28 | Q2 | MAGNET STRATEGY GROUP | 401104125 | MEDICAGO INC. | 2017 | second_quarter | MED | Importance of biopharmaceutical platforms to strengthen preparedness against future outbreaks in emerging infectious disease. | HOUSE OF REPRESENTATIVES,SENATE | 7000 | 0 | 0 | 2017-07-17T15:07:33.333000-04:00 | |
| 1989762 | ALEXION PHARMACEUTICALS, INC. be46da7c-fb01-4468-8026-f1de499c2bef | Q2 | ALEXION PHARMACEUTICALS, INC. | 400504482 | ALEXION PHARMACEUTICALS, INC. | 2017 | second_quarter | MED | PDUFA Reauthorization Right-to-Try Legislation RACE for Children Act | HOUSE OF REPRESENTATIVES,SENATE | 299245 | 0 | 0 | 2017-07-17T15:14:56.100000-04:00 | |
| 1989933 | FAEGRE DRINKER BIDDLE & REATH LLP 48e0ff8a-b2a3-42ed-a2db-9014b79a8fc4 | Q2 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2017 | second_quarter | MED | Public Health Programs for Infectious and Tropical Disease; NIH Research; Issues related to government agency conference travel; Draft domestic neglected tropical disease legislation. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-17T15:54:10.557000-04:00 | |
| 1989982 | FRANCIS EDWARD & CRONIN, INC. 93223273-9125-4faa-9d14-fb471c4632d0 | 2A | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2017 | second_quarter | MED | Issues and legislation related to diabetes diagnosis and treatment. | HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 0 | 2017-07-17T15:56:21.917000-04:00 | |
| 1990056 | KD ADVOCACY AND CONSULTING, LLC babba992-67b1-4ece-8ca5-45588e0a1f54 | Q2 | KD ADVOCACY AND CONSULTING, LLC | 401103971 | REACHING MILESTONES | 2017 | second_quarter | MED | Advocating to improve coverage and access to autism treatment services for TRICARE beneficiaries. | Defense, Dept of (DOD) | 0 | 0 | 2017-07-17T16:15:14.920000-04:00 | ||
| 1990503 | THORN RUN PARTNERS 789a214d-661a-49d4-87d9-34e41d131bc2 | Q2 | THORN RUN PARTNERS | 400534596 | CONTINUING MEDICAL EDUCATION COALITION | 2017 | second_quarter | MED | Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-17T23:15:04.557000-04:00 | |
| 1990512 | THORN RUN PARTNERS 3e35f72f-e8e3-4ddf-b113-75c140760d3c | Q2 | THORN RUN PARTNERS | 400534596 | NOVARTIS CORPORATION | 2017 | second_quarter | MED | Issues related to biologics. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-17T23:37:14.403000-04:00 | |
| 1990523 | CARDINAL HEALTH, INC. aa430653-7743-4083-9f6c-2d016cca9791 | Q2 | CARDINAL HEALTH, INC. | 58055 | CARDINAL HEALTH INC | 2017 | second_quarter | MED | H.R. 6: 21st Century Cures Act (entire bill) - implementation Medical Device Tax | HOUSE OF REPRESENTATIVES,SENATE | 360000 | 0 | 0 | 2017-07-17T23:54:10.717000-04:00 | |
| 1990524 | THORN RUN PARTNERS 7906c91d-d723-4ee2-a630-3adbb16a2be5 | Q2 | THORN RUN PARTNERS | 400534596 | CHILDRENS HOSPITAL COLORADO | 2017 | second_quarter | MED | H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Issues related to pediatric research and childrens hospital graduate medical education. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2017-07-17T23:56:12.920000-04:00 | |
| 1990528 | THORN RUN PARTNERS a1d011a2-181d-482c-9cb6-d8033f5b82b5 | Q2 | THORN RUN PARTNERS | 400534596 | ABBOTT LABORATORIES | 2017 | second_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2017-07-17T23:58:14.420000-04:00 | |
| 1990593 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH a41c575e-8440-4db6-8fe4-560765b76d21 | Q2 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 314055 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 2017 | second_quarter | MED | Federal Support for the National Institutes of Health and the National Eye Institute | HOUSE OF REPRESENTATIVES,SENATE | 61406 | 0 | 0 | 2017-07-18T08:34:34.790000-04:00 | |
| 1990677 | THORN RUN PARTNERS ab4dcd5b-7b02-420f-a55e-59563fcdf7c5 | Q2 | THORN RUN PARTNERS | 400534596 | ABBVIE INC. | 2017 | second_quarter | MED | Issues related to National Institutes of Health (NIH), Centers for Disease Control (CDC), and other funding. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-18T09:30:36.813000-04:00 | |
| 1990745 | TRAVERE THERAPEUTICS 06dd84cb-d3f6-4b91-8875-64ffcd0e3e1a | Q2 | TRAVERE THERAPEUTICS | 401104190 | TRAVERE THERAPEUTICS | 2017 | second_quarter | MED | Medical research, NIH funding, FDA personnel issues | HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2017-07-18T09:55:26.940000-04:00 | |
| 1990788 | WINNING STRATEGIES WASHINGTON 4f95de11-7bf9-4531-b6d7-dba79ecde09c | Q2 | WINNING STRATEGIES WASHINGTON | 50796 | ALGOMETRX, INC. | 2017 | second_quarter | MED | Research and development of advanced pain assessment and diagnostic technology | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2017-07-18T10:03:54.147000-04:00 | |
| 1990873 | LNE GROUP d8c26b91-2806-49e3-a124-62441844436d | Q2 | LNE GROUP | 308811 | HOSPICE OF THE WESTERN RESERVE | 2017 | second_quarter | MED | Lobbied on issues related to medical/disease research. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 30000 | 0 | 0 | 2017-07-18T10:26:54.273000-04:00 | |
| 1990981 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bf4ab19c-95ca-464b-a698-b11146c2a7a8 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2017 | second_quarter | MED | Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention. FY 2017, Defense Appropriations, FY 2017 defense health program, Tuberous Sclerosis Complex Research Program HR 244, FY 17 Consolidated Appropriation Act, defense and NIH medical research HR 3219, FY 18 Defense Appropriations Act, Tuberous Sclerosis Medical Research program | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2017-07-18T10:49:57.603000-04:00 | |
| 1991011 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b858465c-6fff-4f4d-81a9-74c1f1837dc3 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION | 2017 | second_quarter | MED | Research opportunities at the Department of Defense and the Centers for Disease Control. FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders. FY 2017, Defense Appropriations Act, defense health programs. HR 1628, American Health Care Act, Medicaid and Essential Health Benefits HR 244, FY 17 Consolidated Appropriations Act, defense medical research and CDC funding for HHT surveillance HR 3219, FY 18 Defense Appropriations Act, defense medical research | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2017-07-18T10:58:20.573000-04:00 | |
| 1991044 | LNE GROUP 70b70818-e80b-4e01-9499-11f6ab3fd3d7 | Q2 | LNE GROUP | 308811 | PARKER HANNIFIN | 2017 | second_quarter | MED | Lobbied for issues related to medical research. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-07-18T11:00:32.073000-04:00 | |
| 1991059 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 6ab07f36-1d77-4da4-9a26-89129d5074b4 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN BRAIN TUMOR ASSOCIATION | 2017 | second_quarter | MED | FY 17, Defense Appropriations Act, cancer research, HR 1301 FY 17, Labor-HHS-Education Appropriations Act, S 3040/HR 5926 NIH, Cancer Research FY 18, Defense Appropriations Act, cancer research HR 244, FY 17 Consolidated Appropriations Act, defense medical research programs HR 3219, FY 18 Defense Appropriations Act, defense medical research programs | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2017-07-18T11:02:45.307000-04:00 | |
| 1991063 | THORN RUN PARTNERS 84a468d9-7605-469a-87dc-21949f99baa9 | Q2 | THORN RUN PARTNERS | 400534596 | GLAUKOS CORPORATION | 2017 | second_quarter | MED | Issues related to medical technology used for the treatment of glaucoma. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-18T11:02:46.840000-04:00 | |
| 1991343 | PUBLIC SPHERE, INC. 91c4ef77-b1b7-4172-b663-d47795c65980 | Q2 | PUBLIC SPHERE, INC. | 401104153 | SI-BONE | 2017 | second_quarter | MED | General company overview for members and staff. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-18T12:02:22.047000-04:00 | |
| 1991479 | CAPITOL HILL STRATEGIES, LLC 6badb757-014c-4e34-95f8-6c2a8575e1b6 | Q2 | CAPITOL HILL STRATEGIES, LLC | 91774 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2017 | second_quarter | MED | H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA). | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-07-18T12:43:52.007000-04:00 | |
| 1991496 | CAPITOL HILL STRATEGIES, LLC 9c863313-bc09-450c-a38a-e682718e5be4 | Q2 | CAPITOL HILL STRATEGIES, LLC | 91774 | BIOGEN INC | 2017 | second_quarter | MED | Issues dealing with newborn screening. H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA). Issues dealing with Alzheimer's treatments | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2017-07-18T12:47:58.803000-04:00 | |
| 1991512 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) cade23e2-6ce0-4b5e-a2a5-31b8a08e9d47 | Q2 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2017 | second_quarter | MED | AACC met with House and Senate members and staff to express concerns about legislative efforts to extend Food and Drug Administration oversight to laboratory developed tests, which are currently regulated by the Centers for Medicare and Medicaid Services under CLIA'88. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-07-18T12:49:03.083000-04:00 | |
| 1991547 | WINNING STRATEGIES WASHINGTON 5813cb73-2f83-4fe7-a724-541649ce066d | Q2 | WINNING STRATEGIES WASHINGTON | 50796 | HEALTHCARE INSTITUTE OF NEW JERSEY | 2017 | second_quarter | MED | Monitor Prescription Drug User Fee Act re-authorization | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-18T12:53:19.553000-04:00 | |
| 1991563 | AMERICAN PHYSICAL THERAPY ASSOCIATION e401708b-9a45-45c4-8cf7-4273546822d7 | Q2 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2017 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding AHRQ Quality measure development panel for hip fracture patients and fall risk in PAC Comments on Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Known Risk Factors PT role in childhood obesity Relocate TBI State Grant Program to ACL SAFE PLAY Act | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Veterans Affairs, Dept of (VA),White House Office | 246629 | 0 | 0 | 2017-07-18T12:57:29.147000-04:00 | |
| 1991577 | THORN RUN PARTNERS bd07793f-b513-4293-8162-c71cf216655d | Q2 | THORN RUN PARTNERS | 400534596 | HACKENSACK MERIDIAN HEALTH | 2017 | second_quarter | MED | H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Issues relating to research funding, NIH and other matters. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-18T13:00:22.657000-04:00 | |
| 1991735 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS eb065a38-58d3-4a9f-9111-656d9a5ab024 | Q2 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS | 52105 | AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS | 2017 | second_quarter | MED | Work to enhance funding for NIH. Support funding for the Peer Reviews Orthopaedic Research Program | HOUSE OF REPRESENTATIVES,SENATE | 461408 | 0 | 0 | 2017-07-18T13:40:24.760000-04:00 | |
| 1991765 | WINNING STRATEGIES WASHINGTON 369d0c91-3fdd-43a7-9fd7-2ffec8631bba | Q2 | WINNING STRATEGIES WASHINGTON | 50796 | LAHEY HEALTH | 2017 | second_quarter | MED | Rural wage index Medicare Reform | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-18T13:41:36.950000-04:00 | |
| 1991854 | UNIVERSITY OF MIAMI c85e5b7b-db90-4f88-8d6a-4367c2bf097d | Q2 | UNIVERSITY OF MIAMI | 39462 | UNIVERSITY OF MIAMI | 2017 | second_quarter | MED | Department of Defense Appropriations. | Defense, Dept of (DOD) | 108032 | 0 | 0 | 2017-07-18T13:54:43.077000-04:00 | |
| 1992222 | WEBMD HEALTH CORP. 9a3d04f6-67b9-438a-90d9-33d856c1a7c3 | Q2 | WEBMD HEALTH CORP. | 55473 | WEBMD HEALTH CORP | 2017 | second_quarter | MED | Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-07-18T14:48:59.487000-04:00 | |
| 1992244 | AMERICAN ACADEMY OF PEDIATRICS 3b37bd1c-a31c-472b-ad10-b286afe73a79 | Q2 | AMERICAN ACADEMY OF PEDIATRICS | 1397 | AMERICAN ACADEMY OF PEDIATRICS | 2017 | second_quarter | MED | Fetal Tissue Research Environmental influences on Child Health Outcomes Drugs and Devices | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),U.S. Agency for International Development (USAID),White House Office | 90271 | 0 | 0 | 2017-07-18T14:51:15.130000-04:00 | |
| 1992281 | AMERICAN ACADEMY OF PEDIATRICS 5142711e-4231-4e00-a553-0e2ffeeb7484 | 2A | AMERICAN ACADEMY OF PEDIATRICS | 1397 | AMERICAN ACADEMY OF PEDIATRICS | 2017 | second_quarter | MED | Fetal Tissue Research Environmental influences on Child Health Outcomes Drugs and Devices | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),U.S. Agency for International Development (USAID),White House Office | 90271 | 0 | 0 | 2017-07-18T14:54:34.147000-04:00 | |
| 1992342 | AMERICAN ACADEMY OF PEDIATRICS 9af3226d-58c9-4a53-aac6-ddca5787628c | 2A | AMERICAN ACADEMY OF PEDIATRICS | 1397 | AMERICAN ACADEMY OF PEDIATRICS | 2017 | second_quarter | MED | Fetal Tissue Research Environmental influences on Child Health Outcomes Drugs and Devices | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),U.S. Agency for International Development (USAID),White House Office | 0 | 0 | 2017-07-18T14:58:02.350000-04:00 | ||
| 1993590 | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 9793f7dc-0680-47aa-821e-2f9863c5fc75 | Q2 | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | 401103415 | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | 2017 | second_quarter | MED | Implementation of the 21st Century Cures Act, provisions related to pediatric training and research. Establishment of a pediatric program office or coordinating council at the National Institutes of Health. | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2017-07-18T18:49:53.267000-04:00 | |
| 1993591 | FTI GOVERNMENT AFFAIRS 5f9cf962-0c5c-47e6-864a-2e13a7f05d5c | Q2 | FTI GOVERNMENT AFFAIRS | 401054971 | HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY | 2017 | second_quarter | MED | Monitor developments related to Electronic Health Records. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-18T18:50:54.610000-04:00 | |
| 1994151 | WILLIAMS AND JENSEN, PLLC 9037f7a7-e017-4f54-ab88-6debbe51f526 | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | VERTEX PHARMACEUTICALS INCORPORATED | 2017 | second_quarter | MED | Prescription drug user fee agreements and general education about FDA approval policies and NIH research activities. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-19T08:47:33.303000-04:00 | |
| 1994156 | WILLIAMS AND JENSEN, PLLC 67d6a289-8794-464b-baab-9c8e74a45dcf | Q2 | WILLIAMS AND JENSEN, PLLC | 41454 | BIOGEN IDEC | 2017 | second_quarter | MED | Prescription drug user fee agreements and general education about FDA approval polices and NIH research activities. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-07-19T08:48:36.117000-04:00 | |
| 1994286 | WASHINGTON STATE UNIVERSITY de44bd97-549f-491a-aa6a-003c694ba192 | Q2 | WASHINGTON STATE UNIVERSITY | 40657 | WASHINGTON STATE UNIVERSITY | 2017 | second_quarter | MED | Medical Education, antimicrobial resistance | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),Office of Science & Technology Policy (OSTP),SENATE,White House Office | 60040 | 0 | 0 | 2017-07-19T09:22:02.730000-04:00 | |
| 1994554 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 518acb73-6ae4-416d-9d29-987a91550bad | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | 23ANDME, INC. | 2017 | second_quarter | MED | Direct to consumer genetic testing Regulation and oversight of diagnostics | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE | 20000 | 0 | 0 | 2017-07-19T10:17:13.330000-04:00 | |
| 1994569 | TRAVERE THERAPEUTICS 030a4f97-e7a9-4db6-9177-e55b11420a48 | 2A | TRAVERE THERAPEUTICS | 401104190 | TRAVERE THERAPEUTICS | 2017 | second_quarter | MED | Medical research, NIH funding, FDA personnel issues | HOUSE OF REPRESENTATIVES,SENATE | 170000 | 0 | 0 | 2017-07-19T10:19:20.580000-04:00 | |
| 1994628 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d3f72a8c-7060-4b88-9b0a-9ce403cda293 | 2T | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | CURE FORWARD | 2017 | second_quarter | MED | Cancer Moonshot Patient Access to lab results | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2017-07-19T10:25:54.940000-04:00 | |
| 1994721 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ba687529-6126-4614-b25f-73879c887456 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2017 | second_quarter | MED | Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office | 60000 | 0 | 0 | 2017-07-19T10:39:06.127000-04:00 | |
| 1994922 | BUCHANAN INGERSOLL & ROONEY PC dc95950d-8027-43bc-9ddf-b917ef1e2801 | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | WOMEN'S CHOICE PHARMACEUTICALS, LLC | 2017 | second_quarter | MED | Development of government relations strategy relating to prenatal dietary supplements. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-07-19T11:00:03.663000-04:00 | |
| 1995026 | LOBBYIT.COM 6e35d114-0f45-49ad-b0dc-75a9eb6b2d01 | Q2 | LOBBYIT.COM | 400487397 | BLADDER CANCER ADVOCACY NETWORK | 2017 | second_quarter | MED | Increase awareness of bladder cancer. Advocate in support of a bladder cancer specific direct line of funding within the CDMRP, designating May as "Bladder Cancer Awareness Month". | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-07-19T11:12:11.647000-04:00 | |
| 1995125 | UNIVERSITY OF IOWA b5860689-908c-40d3-85eb-941e77cd48c8 | Q2 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2017 | second_quarter | MED | Support for all federal agencies that fund medical and disease research FY 17 and FY 18 appropriations for HHS, NIH, CDC, and DOD FY 17 and FY 18 appropriations for Injury Prevention Centers at CDC | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 86662 | 0 | 0 | 2017-07-19T11:19:05.057000-04:00 | |
| 1995477 | AMERICAN SOCIETY OF HEMATOLOGY 382d4926-58fa-4730-bc26-42da7b881ff5 | Q2 | AMERICAN SOCIETY OF HEMATOLOGY | 59171 | AMERICAN SOCIETY OF HEMATOLOGY | 2017 | second_quarter | MED | Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2017-07-19T11:48:59.637000-04:00 | |
| 1995528 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS b1b9e335-bd31-4dba-83f9-bf4cfe01f8a0 | Q2 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 1672 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 2017 | second_quarter | MED | Advocating in support of increased NIH funding in the FY 2018 Labor-HHS-Education Appropriations bill. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 138197 | 0 | 0 | 2017-07-19T11:54:31.293000-04:00 | |
| 1995654 | SQUIRE PATTON BOGGS 3a4a27e7-ccdf-4121-80d2-0c808269c4ac | Q2 | SQUIRE PATTON BOGGS | 30906 | UNIVERSITY OF GEORGIA | 2017 | second_quarter | MED | Traumatic brain injury research, funding, and outreach opportunities. Zika research funding. | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS) | 40000 | 0 | 0 | 2017-07-19T12:12:01.873000-04:00 | |
| 1995685 | HOGAN LOVELLS US LLP 79540839-e5e0-474d-967f-91cc1d46a7f5 | Q2 | HOGAN LOVELLS US LLP | 18422 | COLDCHAIN TECHNOLOGY SERVICES | 2017 | second_quarter | MED | Pursuing opportunities for better logistical application for storage and delivery of vaccines. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-19T12:16:28.373000-04:00 | |
| 1996418 | VAN SCOYOC ASSOCIATES 1d21c9af-f1d3-4d7d-9053-ff8f5242eb89 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF NOTRE DAME | 2017 | second_quarter | MED | Zika virus research and development related issues | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-07-19T13:39:53.493000-04:00 | |
| 1996574 | LOCKRIDGE, GRINDAL, NAUEN, PLLP d5b7652a-1228-474f-94f5-68e042e8b68f | Q2 | LOCKRIDGE, GRINDAL, NAUEN, PLLP | 23053 | HENNEPIN COUNTY MEDICAL CENTER | 2017 | second_quarter | MED | FY2018 Authorizations, Appropriations, and Budget Policy | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2017-07-19T13:50:24.387000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);